To define the clinical relevance of PKM2 S222 phosphorylation, we performed immunohistochemistry (IHC) analyses in the tumor tissues from human primary glioblastoma multiforme (GBM) patients using anti‐PKM2 pS222 antibody. This evidence concerns the gene PKM and neoplasm.